Aesthetic distributor Healthxchange has announced a partnership with Growth Partner, a strategic operator founded by entrepreneur Sir Richard Harpin. According to Healthxchange, Growth Partner works with successful, founder-led businesses, providing
A new £50 million Medical Research Council (MRC) Centre for Research Excellence in Restorative Immunology, led by the University of Birmingham, has launched to advance research towards cures for immune-mediated
Skincare company iS Clinical has announced a new partnership with UK medical aesthetics clinic ALTA Medi, based in Marylebone, London. According to iS Clinical, the doctor-led clinic was founded by
The Joint Council for Cosmetic Practitioners (JCCP) has appointed Lloyd Bracey as its new chair, and Andrew Rankin as registrar. Following the retirement of previous chair Professor David Sines, Bracey
Skincare company AlumierMD has announced aesthetic practitioner Dr Tom Kamal as a UK key opinion leader (KOL). AlumierMD shares that Dr Kamal will work closely with the professional skincare brand
The Joint Council for Cosmetic Practitioners (JCCP) has published new guidance for platelet-rich plasma (PRP) procedures within medical aesthetic settings. This guidance was developed by a panel of health protection
Medical device company Dermalux has introduced Rachel Hand as a new territory business manager for Ireland. Following her previous role with skincare company AlumierMD as business growth partner and account
The British College of Aesthetic Medicine (BCAM) has announced aesthetic practitioner Dr Rebecca Norman as its latest vice president. The organisation shares that Dr Norman will support the president and
Aesthetic distributor Healthxchange has announced its exclusive distribution of the Potenza radiofrequency (RF) microneedling system in the UK and Ireland. According to the company, the Potenza system combines monopolar and
Pharmaceutical company IBSA Derma, the UK and Ireland subsidiary of global pharmaceutical leader IBSA, has announced that it will assume responsibility for the distribution of injectables Profhilo, Aliaxin and Viscoderm.
